Bossuyt, Xavier, Cooreman, Sarah, De Baere, Heidi et al. · Clinica chimica acta; international journal of clinical chemistry · 2013 · DOI
This study tested an automated machine to detect antinuclear antibodies (ANA)—proteins the immune system sometimes makes that can be seen in blood tests. Researchers compared how well this automated system worked compared to traditional methods, using blood samples from people with autoimmune diseases, healthy donors, people with chronic fatigue syndrome, and other patient groups. The machine was good at collecting images but had difficulty identifying the specific patterns of these antibodies accurately.
Some ME/CFS patients have atypical immune markers or overlap with autoimmune conditions. Understanding how automated ANA testing performs—particularly in distinguishing true positives from false positives—helps researchers and clinicians accurately identify when immune system dysfunction is present and avoid misdiagnosis as purely rheumatologic disease.
This study does not prove that ME/CFS is an autoimmune disease or that ANA testing should be used to diagnose ME/CFS. The inclusion of a CFS group was observational for comparison purposes; the study does not establish a causal link between ANA positivity and ME/CFS pathology. The findings apply specifically to automated systems and may not reflect all current diagnostic approaches.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →